Abstract
The stratum corneum, the outer layer of the epidermis, serves as a protective barrier to isolate the skin from the external environment. Keratinocyte transglutaminase 1 (TGase 1) catalyzes amide crosslinking between glutamine and lysine residues on precursor proteins forming the impermeable layers of the epidermal cell envelopes (CE), the highly insoluble membranous structures of the stratum corneum. Patients with the autosomal recessive skin disorder lamellar ichthyosis (LI) appear to have deficient cross-linking of the cell envelope due to mutations identified in TGase 1, linking this enzyme to LI. In the absence of a crystal structure, molecular modeling was used to generate the structure of TGase 1. We have mapped the known mutations of TGase 1 from our survey obtained from a search of PubMed and successfully predicted the impact of these mutations on LI. Furthermore, we have identified Ca2+ binding sites and propose that Ca2+ induces a cis to trans isomerization in residues near the active site as part of the enzyme transamidation activation. Docking experiments suggest that substrate binding subsequently induces the reverse cis to trans isomerization, which may be a significant part of the catalytic process. These results give an interpretation at the molecular level of previously reported mutations and lead to further insights into the structural model of TGase 1, providing a new basis for understanding LI.
Similar content being viewed by others
Abbreviations
- TGase 1:
-
keratinocyte transglutaminase 1
- LI:
-
lamellar ichthyosis
- GTP:
-
guanosine 5′-triphosphate
- RMSD:
-
root mean square deviation
- DTT:
-
1,4-dithio-dl-threitol
- EDTA:
-
ethylenediaminetetraacetic acid
- TCA:
-
trichloroacetic acid
- CE:
-
cell envelope
- SPRs:
-
small proline-rich proteins
- SCRs:
-
structurally conserved regions
- SVRs:
-
structurally variable regions
- MolCad:
-
computer aided molecular design
- CTI:
-
cis to trans isomerization
References
Anton-Lamprecht I (1992) The skin. In: Papadimitriou JM, Henderson DW, Spagnolo DV (eds) Diagnostic ultrastructure of non-neoplastic diseases. Edinburgh, Churchill and Livingstone, pp 459–550
Williams ML, Elias PM (1985) Arch Dermatol 121:477–488
Russell LJ, DiGiovanna JJ, Rogers GR, Steinert PM, Hashem N, Compton JG, Bale SJ (1995) Nat Genet 9:279–283
Russell LJ, DiGiovanna JJ, Hashem N, Compton JG, Bale SJ (1994) Am J Hum Genet 55:114–1152
Laiho E, Niemi KM, Ignatius J, Kere J, Palotie A, Saarialho-Kere U (1999) Eur J Hum Genet 7:625–632
Laiho E, Ignatius J, Mikkola H, Yee VC, Teller DC, Niemi KM, Saarialho-Kere U, Kere J, Palote A (1997) Am J Hum Genet 61:529–538
Williams M, Elias PM (2000) Curr Probl Dermatol 12:170–176
Huber M, Rettler I, Bernasconi K, Frenk E, Lavrijsen SP, Ponec M, Bon A, Lautenschlager S, Schorderet DF, Hohl D (1995) Science 267:525–528
Choate KA, Williams ML, Khavari PA (1998) J Invest Dermatol 110:8–12
Liu S, Cerione RA, Clardy J (2002) Proc Natl Acad Sci 99:2743–2747
Ahvazi B, Boeshans KM, Idler W, Baxa U, Steinert PM, Rastinejad F (2004) J Biol Chem 279:7180–7192
Kim IG, McBride W, Wang M, Kim SY, Idler WW, Steinert PM (1992) J Biol Chem 267:7710–7717
Steinert PM, Kim SY, Chung SI, Marekov LN (1996) J Biol Chem 271:26242–26250
Nemes Z, Marekov LN, Fesüs L, Steinert PM (1996) Proc Natl Acad Sci 96:8402–8407
Phillips MA, Stewart BE, Qin Q, Chakravarty R, Floyd EE, Jetten AM, Rice RH (1990) Proc Natl Acad Sci 87:9333–9337
Phillips MA, Qin Q, Mehrpouyan M, Rice RH (19923) Biochemistry 32:11057–11063
Pilgram GSK, Vissers DCJ, van der Meulen H, Pavel S, Lavrijsen SPM, Bouwstra JA, Koerten HK (2001) J Invest Dermatol 117:710–717
Hennies HC, Kuster W, Wiebe V, Krebsova A, Reis A (1998) Am J Hum Genet 62:1052–1061
Gish W (1996–2002) http://blast.wustl.edu/blast/
Godzik A, Kolinski A, Skolnick J (1992) J Mol Biol 227:227–238
McGuffin LJ, Bryson K, Jones DT (2000) Bioinformatics 16:404–405
Lüthy R, Bowie JU, Eisenberg D (1992) Nature 356:83–85
Sabnis Y, Desai PV, Rosenthal PJ, Avery MA (2003) Prot Sci 12:501–509
Jones TA, Thirup S (1986) EMBO J 5:819–822
Stouten PFW, Froemmel C, Nakamura H, Sander C (1993) Mol Simul 10:97–120
Greengard L, Rokhlin VI (1987) J Comp Phys 73:325–348
Verlet L (1967) Phys Rev 159:98–103
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1992) J Appl Cryst 26:283–291
Merritt EA, Bacon DJ (1997) Method Enzymol 277:505–525
Kraulis PJ (1991) J Appl Cryst 24:946–950
SYBYL 6.7 (1995) Tripos Assoc. Inc., St. Louis, MO
Ahvazi B, Kim HC, Kee SH, Nemes Z, Steinert PM (2002) EMBO J 21:2055–2067
Ahvazi B, Boeshans KM, Jang S-I, Kalinin P, Steinert PM (2002) Minerva Biotecnol 14:165–169
Ahvazi B, Boeshans KM, Idler W, Baxa U, Steinert PM (2003) J Biol Chem 278:23834–23841
Ahvazi B, Boeshans KM, Steinert PM (2004) J Biol Chem 279:26716–26725
Menon GK, Elias PM (1991) Arch Dermatol 127:57–63
Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH (1980) Cell 19:245–254
Ahvazi B, Steinert PM (2003) Exp Mol Med 35:228–242
Ahvazi B, Boeshans KM, Rastinejad F (2004) J Struct Biol 147:200–207
Weiss MS, Jabs A, Hilgenfeld R (1998) Nat Struct Biol 5:676
Jabs A, Weiss MS, Hilgenfeld R (1999) J Mol Biol 286:291–304
Stoddard BL, Pietrokovski S (1998) Nat Struct Biol 5:3–5
Folkers G (1998) In: Codding PW (ed) Structure-based drug design: experimental and computational approaches. Kluwer Academic Publisher, Norwell, MA, pp 271–283
Candi E, Tarcsa E, Idler WW, Kartasova T, Marekov LN, Steinert PM (1999) J Biol Chem 274:7226–7237
Ludwig M, Pattridge K, Metzger A, Dixon M, Eren M, Feng Y, Swenson R (1997) Biochemistry 36:1259–1280
Heroux A, White E, Ross L, Davis R, Borhani D (1999) Biochemistry 38:14495–14506
Stewart D, Sarkar A, Wampler J (1990) J Mol Biol 214:253–260
Lin LN, Brandts JF (1993) Biochemistry 22:564–573
Scherer G, Kramer M, Schutkowski M, Reimer U, Fischer G (1998) J Am Chem Soc 120:5568–5579
Schiene-Fischer C, Fischer G (2001) J Am Chem Soc 123:6227–6231
Reimer U, Fischer G (2002) Biophys Chemist 96:203–212
Acknowledgments
We thank Dr. Henry Hennings of NCI’s Laboratory of Cellular Carcinogenesis and Tumor Formation for critical review of our manuscript. We are indebted to Dr. Ellis Kempner for stimulating discussion and critical review of this manuscript. This research was supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper is dedicated to the memory of Dr. Peter M. Steinert (April 7, 2003).
Rights and permissions
About this article
Cite this article
Boeshans, K.M., Mueser, T.C. & Ahvazi, B. A three-dimensional model of the human transglutaminase 1: insights into the understanding of lamellar ichthyosis. J Mol Model 13, 233–246 (2007). https://doi.org/10.1007/s00894-006-0144-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-006-0144-9